Phase II study of ironotecan plus capecitabine in patients with antracycline and taxane pretreated metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 29 Dec 2011
At a glance
- Drugs Capecitabine; Irinotecan
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 29 Dec 2011 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 29 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Oct 2007 New trial record.